Caitlin Sullivan
Pediatrics · Atlanta, GANPI 1861926313
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.9% of the total across 291 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 11.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,112 and has fallen 95.5% since, to $95 in 2025. Among pediatrics clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 291 payments — averaging $22.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$731
- Abbott$721
- AbbVie$716
- Novo Nordisk$588
- Xeris Pharmaceuticals, Inc.$550
- Ascendis Pharma Endocrinology Inc$488
- plus $3K from 30 others
What the payments were for
- Speaking & faculty fees$5809%
- Food & beverage$5,82891%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 10 | $731 |
| Abbott | 46 | $721 |
| AbbVie | 42 | $716 |
| Novo Nordisk | 31 | $588 |
| Xeris Pharmaceuticals, Inc. | 32 | $550 |
| Ascendis Pharma Endocrinology Inc | 17 | $488 |
| Sanofi-aventis U.S. LLC | 8 | $328 |
| Tandem Diabetes Care, Inc. | 9 | $235 |
| Insulet Corporation | 9 | $229 |
| Lilly USA, LLC | 9 | $145 |
| Tolmar, Inc. | 8 | $137 |
| Embecta Corp. | 6 | $124 |
| AstraZeneca | 6 | $121 |
| Endo Pharmaceuticals Inc. | 6 | $114 |
| Azurity Pharmaceuticals, Inc. | 5 | $103 |
| Corcept Therapeutics | 5 | $101 |
| Zealand Pharma US, Inc. | 5 | $99 |
| Dexcom, Inc. | 4 | $96 |
| Ferring Pharmaceuticals Inc. | 3 | $83 |
| IBSA Pharma Inc. | 2 | $79 |
| Kyowa Kirin, Inc. | 4 | $77 |
| Amneal Pharmaceuticals LLC | 3 | $64 |
| Amphastar Pharmaceuticals, Inc. | 3 | $62 |
| Eton Pharmaceuticals, Inc. | 2 | $61 |
| Medtronic | 2 | $54 |
| Mannkind Corporation | 3 | $44 |
| BETA Bionics, Inc. | 2 | $43 |
| Amgen | 1 | $30 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $25 |
| Endo USA, Inc. | 1 | $24 |
| Averitas Pharma Inc. | 1 | $23 |
| BD | 1 | $22 |
| Biomarin Pharmaceutical Inc. | 1 | $22 |
| Bayer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,408 in reported general payments places this provider in the 95th percentile of 2,111 pediatrics providers in Georgia.
Other pediatrics in Atlanta
- Amir AshrafiAtlanta$563K
- Satheesh ChonatAtlanta$147K
- Karen ZimowskiAtlanta$139K
- Iyabode Akinsanya-BeysolowAtlanta$103K
- Lauren MiddlebrooksAtlanta$71K
- Rebecca EmoryAtlanta$40K
- Mark GriffithsAtlanta$34K
- Kelly TickleAtlanta$29K
- Robert WiskindAtlanta$21K
- Mary BertossiAtlanta$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.